Moving Medicine Forward

In this episode of Moving Medicine Forward , host Jeremy Schrand welcomes Dr. Rich Curry to discuss how CTI is helping redefine what’s possible in clinical research. From the complexities of cell and gene therapy to the human stories behind the science, Dr. Curry shares how CTI’s expertise in rare diseases and regenerative medicine is accelerating innovation and improving patient outcomes. Discove...

In this episode of “Moving Medicine Forward,” SavannahDoliboa, Chief Commercial Officer at CTI, shares her career journey and what led her to CTI, a company that combines the strengths of both large and mid-sized CROs. She reflects on the rewards of working with rare disease sponsors, CTI’s diverse client base, and its reputation for flexibility, expertise, and lasting partnerships. Savannah also...

In this episode of “Moving Medicine Forward,” Audrey Davidow shares how her son’s diagnosis led to her co-founding the Pitt Hopkins Research Foundation. She explains the rare genetic disorder, the foundation’s focus on research and family support, and major breakthroughs such as a gene therapy trial. Audrey also reflects on advocacy, leadership challenges, and the hope driving their mission forwar...

Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials. Topics Covered: CTI’s history and expansion in...

In this episode of “Moving Medicine Forward,” Tara Mink,expert in cell and gene therapy for more than 25 years, joins to discuss the science, promise, and challenges of CAR-T therapy. Tara explains how CAR-T works, its remarkable durability, and the side effects clinicians manage. She also discusses the future of gene therapy, barriers to access, and how the field is expanding into new disease are...

In this episode of “Moving Medicine Forward,” host Jeremy Strand sits down with Brian Lawrence, Chief Financial Officer at CTI, to explore how strategic financial planning is critical to advancing clinical trials, particularly in rare disease research. Brian shares insights on balancing profitability with purpose in one of the world’s most highly regulated industries, reflecting on early career de...

What makes a clinical trial site successful when managing complex transplant studies? In this episode of “Moving Medicine Forward,” host Jeremy Schrand is joined by Shawna Bredek, a 20+ year veteran in clinical trial operations, to explore how feasibility assessments shape the future of life-saving research. Shawna shares how her team evaluates sites, navigates post-COVID challenges, tackles regul...

In this episode of Moving Medicine Forward, we sit down with Dr. Helios Tedesco, a globally recognized transplant nephrologist from São Paulo, Brazil, who leads one of the world’s largest kidney transplant programs. Joined by CTI experts Dr. Christopher Boshkos, Senior Medical Director, and Clinical Scientist, Erika Aldag, the conversation explores the challenges and innovations behind managing mo...

In this episode of “Moving Medicine Forward” – The Podcast, Jamie Meisenhelder, Chief Administrative Officer (CAO) at CTI, joins us to reflect on her unique journey from law to leadership and how she oversees CTI’s legal, QA, and administrative functions. She shares how her team supports clinical trials, tackles global regulatory challenges, maintains quality standards, and keeps patient trust as...

In this episode, Jeremy sits down with Sara Russo and John Mock from Network for Hope, an independent nonprofit organ procurement organization. Together, they explore the life-changing work of organ and tissue donation — from the hospital bedside to the recipient's second chance at life.    Learn how the organization evolved from a merger between LifeCenter and KODA, now serving 7 million peop...

In this episode of “Moving Medicine Forward” – The Podcast, Monica Rodriguez, Managing Director of Global Laboratory, Pharmacometrics, and Site Services at CTI, and Andy Supp, Vice President of Global Laboratory Services at CTI, join the conversation to discuss the unique structure and capabilities of CTI’s global laboratories. They share insights into their respective backgrounds, the strategic i...

In this episode of “Moving Medicine Forward” – The Podcast, Pat Dearing, Chief Human Resources Officer at CTI, discusses his career journey and the unique challenges of HR in healthcare. He shares insights on recruiting top talent, "people-first leadership," and CTI's DEIB council. Pat also talks about the future of remote work, HR’s role in acquisitions, and emerging trends shaping the future of...

In this episode of “Moving Medicine Forward” – The Podcast, Christine Eby, Director of Clinical Project Management & Therapeutic Strategy Lead at CTI, Anna Sowa, Chief Mission Officer at CurePDE, Curtis R. Coughlin II, PhD, MS, MBE, Associate Professor, Department of Pediatrics and Center for Bioethics and Humanities, and Kristy McCay, mom of a two-year-old living with pyridoxine-dependent epi...

In this episode of "Moving Medicine Forward" – The Podcast, Jill Black, Validation IT Principal Auditor at CTI, shares the deeply personal story of her daughter, Emma, and their journey navigating this rare disease. She offers valuable insights into the challenges and impact of Rett Syndrome, while discussing her work at CTI and how being part of an organization focused on rare diseases...

In this episode of “Moving Medicine Forward” – The Podcast, Mike Vieth, CTI Board Member and partner at E Gateway Capital, and Tim Schroeder, CTI CEO and Chairman, explore key topics in clinical trial funding. They discuss the role of venture capital in overcoming funding challenges, balancing high-risk investments, and supporting clinical research beyond financial backing. They also dive into how...

In this episode of #MovingMedicineForward – The Podcast, CTI experts Chad Jones & Eric Clayton discuss challenges in clinical research surrounding Acute Myeloid Leukemia (AML) & Multiple Myeloma (MM). They explore the complexities of designing & conducting clinical trials, the importance of site selection, & how CTI’s expertise enhances trial outcomes. Additionally, they touch on k...

In this episode of “Moving Medicine Forward” – The Podcast, Lily McNally and Heidi Shenk from the American Brain Tumor Association (ABTA) share their personal connections to brain tumors and discuss the ABTA’s resources, research initiatives, and community partnerships. They also discuss ABTA’s “Meet Hope Head On” campaign to triple research funding and expand patient outreach. Tune in to learn ho...

In this episode of "Moving Medicine Forward" - The Podcast, Greg Ruf, Founder & Executive Director of the DCM Foundation, and Bret Marshall, Senior Director of Business Development & Client Management at CTI, discuss the vital role of patient advocacy groups and the partnership between CTI and the DCM Foundation. Greg shares his journey in founding the DCM Foundation, and they explore key...

In this special 25th-anniversary episode of "Moving Medicine Forward" - The Podcast, we're excited to welcome Tim Schroeder, Chief Executive Officer of CTI, Lynn Fallon, CTI Board Member and former President, and Kevin Schwarz, Chief Operating Officer of CTI. They share insights into CTI’s founding vision and its evolution over the past quarter-century. Tim and Kevin also discuss how...

In this episode of "Moving Medicine Forward" – The Podcast, Dr. Monica Shah, Chief Medical Officer at CTI, discusses her journey into clinical research and her transition into her new role. Dr. Shah shares her immediate priorities and goals as CMO, her leadership style, and her approach to fostering collaboration within CTI. She also expresses her enthusiasm for the upcoming ARM Cell &am...

In this episode we delve into the world of regulatory interactions, strategy, & operations with two industry leaders: Dr. Monica Rodriguez, Executive Director of Model-Informed Development, & Christine Norman-Tiner, Executive Director of Global Regulatory & Scientific Affairs. They share their invaluable expertise on:  Developing effective regulatory strategies for clinical trials   Na...

In episode 6 of Moving Medicine Forward, we dive into diversity in clinical research with insights from CTI’s CEO Tim Schroeder and Board Member Dr. Bill Fitzsimmons . Hear about Bill's journey into clinical research, the importance of diversity in clinical trials, and strategies to overcome medical mistrust. We also discuss the latest FDA guidance on diversity* and CTI’s initiatives to foster...

Episode 5 assembles experts in transplantation. Tim Schroeder and Dr. Bill Fitzsimmons join us to discuss how CTI has been a key player in the field of transplantation, current trends, and where the future of transplantation is heading. Dr. Robert Gatson discusses transplantation innovations and his own background in the field. 

Episode 4 assembles various CTI experts to discuss Cell and Gene Therapy. In episode 4, Bret Marshall, joins us to discuss CTI’s involvement in Cardiac Cell and Gene trials, our impact, and goals, as well as the current industry trends and advocacy groups. Jaclyn Guillory discussed the groundbreaking advancements in targeted therapies for KRAS mutations. Later in the episode, Michael Schmidt and N...

Today on Moving medicine forward we have a great discussion with Adam Roth, Vice President, Research Site Services at CTI. In this conversation we take a deep dive into how our Clinical Research Center in Cincinnati OH supports clinical research. We focus on the work the site has done on Vaccine trials including how the site supported the Covid-19 Vaccine trials during the pandemic.